37 related articles for article (PubMed ID: 23834620)
1. The Synthesis of 2'-Hydroxychalcones under Ball Mill Conditions and Their Biological Activities.
Abid I; Moslah W; Cojean S; Imbert N; Loiseau PM; Chamayou A; Srairi-Abid N; Calvet R; Baltas M
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675640
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of Chalcone Derivatives as Novel Sunscreen Agent.
Wijayanti LW; Swasono RT; Lee W; Jumina J
Molecules; 2021 May; 26(9):. PubMed ID: 34064528
[TBL] [Abstract][Full Text] [Related]
3. 1,3-diaryl-2-propenones and 2-benzylidene-1,3-indandiones: a quest for compounds displaying greater toxicity to neoplasms than normal cells.
Pati HN; Das U; Sakagami H; Kawase M; Chu Q; Wang Q; Stables JP; Dimmock JR
Arch Pharm (Weinheim); 2010 Sep; 343(9):535-41. PubMed ID: 20806272
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of selenophene-containing flavonols and 2-styrylchromones: Evaluation of their activities compared with selenophene-containing chalcones as potential anticancer agents.
Chen YC; Chang CH; Tang MH; Ding YC; Wu IC; Ye WT; Shih TL
Arch Pharm (Weinheim); 2024 May; ():e2400242. PubMed ID: 38763904
[TBL] [Abstract][Full Text] [Related]
5. Coumarin-chalcone hybrid instigates DNA damage by minor groove binding and stabilizes p53 through post translational modifications.
Ashraf R; Hamidullah ; Hasanain M; Pandey P; Maheshwari M; Singh LR; Siddiqui MQ; Konwar R; Sashidhara KV; Sarkar J
Sci Rep; 2017 Mar; 7():45287. PubMed ID: 28349922
[TBL] [Abstract][Full Text] [Related]
6. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.
Blondel S; Egesipe AL; Picardi P; Jaskowiak AL; Notarnicola M; Ragot J; Tournois J; Le Corf A; Brinon B; Poydenot P; Georges P; Navarro C; Pitrez PR; Ferreira L; Bollot G; Bauvais C; Laustriat D; Mejat A; De Sandre-Giovannoli A; Levy N; Bifulco M; Peschanski M; Nissan X
Cell Death Dis; 2016 Feb; 7(2):e2105. PubMed ID: 26890144
[TBL] [Abstract][Full Text] [Related]
7. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
